Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. 2003

Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

Despite the importance of prostaglandins, little is known about the regulation of prostanoid synthesis proximal to the activation of cytosolic phospholipase A2, the initial rate-limiting step. In this study, ceramide-1-phosphate (C-1-P) was shown to be a specific and potent inducer of arachidonic acid (AA) and prostanoid synthesis in cells. This study also demonstrates that two well established activators of AA release and prostanoid synthesis, the cytokine, interleukin-1beta (IL-1beta), and the calcium ionophore, A23187, induce an increase in C-1-P levels within the relevant time-frame of AA release. Furthermore, the enzyme responsible for the production of C-1-P in mammalian cells, ceramide kinase, was activated in response to IL-1beta and A23187. RNA interference targeted to ceramide kinase specifically down-regulated ceramide kinase mRNA and activity with a concomitant decrease of AA release in response to IL-1beta and A23187. Down-regulation of ceramide kinase had no effect on AA release induced by exogenous C-1-P. Collectively, these results indicate that ceramide kinase, via the formation of C-1-P, is an upstream modulator of phospholipase A2 activation. This study identifies previously unknown roles for ceramide kinase and its product, C-1-P, in AA release and production of eicosanoids and provides clues for potential new targets to block inflammatory responses.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007476 Ionophores Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes. Ionophore
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002518 Ceramides Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE. Ceramide
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations

Related Publications

Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
July 1990, Cytokine,
Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
March 1992, Journal of cellular biochemistry,
Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
June 1995, Cell,
Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
January 1988, Immunopharmacology,
Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
December 1981, Biochemical and biophysical research communications,
Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
January 2010, International journal of physiology, pathophysiology and pharmacology,
Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
December 1989, The American journal of physiology,
Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
March 1987, The Journal of pharmacology and experimental therapeutics,
Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
March 1996, Neuroendocrinology,
Benjamin J Pettus, and Alicja Bielawska, and Sarah Spiegel, and Patrick Roddy, and Yusuf A Hannun, and Charles E Chalfant
September 1987, FEBS letters,
Copied contents to your clipboard!